Curaleaf Holdings (CURLF) Change in Inventory (2019 - 2024)
Curaleaf Holdings (CURLF) posted quarterly Change in Inventory of -$415000.0 for Q4 2024, up 98.49% year-on-year from -$209074.8 in Q1 2024, and up 28.08% on a QoQ basis from -$577000.0 in Q3 2024.
Curaleaf Holdings (CURLF) Change in Inventory (2019 - 2024) Analysis & Trends
Curaleaf Holdings (CURLF) has reported Change in Inventory for 6 consecutive years, with -$415000.0 the latest figure, recorded in Q4 2024.
- Quarterly Change in Inventory rose 98.49% year-over-year to -$415000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was -$4.4 million (down 108.13% YoY) and the FY2025 annual result came in at $3.7 million, up 186.44% from the prior year.
- Change in Inventory improved to -$415000.0 in Q4 2024 per CURLF's latest filing, from -$577000.0 in the prior quarter.
- Over the last five years, Change in Inventory for CURLF reached as high as $56.7 million in Q4 2022 and fell as low as -$59.7 million in Q2 2021.
- A 5-year average of -$10.9 million and a median of -$14.9 million in 2020 frame the typical range for Change in Inventory.
- Annual changes were most pronounced in 2020 — Change in Inventory sank 1670.67% — and 2023, when it jumped 3802.58%.
- Year by year, Change in Inventory stood at -$11.0 million in 2020, then surged by 537.23% to $48.3 million in 2021, then increased by 17.37% to $56.7 million in 2022, then slumped by 148.59% to -$27.5 million in 2023, then surged by 98.49% to -$415000.0 in 2024.
- According to Business Quant data, Change in Inventory over the past three periods registered -$415000.0, -$577000.0, and -$27.5 million for Q4 2024, Q3 2024, and Q4 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -93.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 114.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 119.24 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 40.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 123.00 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -4.30 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Curaleaf Holdings | 7.13 Bn | 7.13 Bn | 157.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -415,000.00 |
| Dec 31, 2024 | -415,000.00 |
| Sep 30, 2024 | -577,000.00 |
| Sep 30, 2024 | -577,000.00 |
| Dec 31, 2023 | -27.55 Mn |
| Dec 31, 2023 | -27.55 Mn |
| Sep 30, 2023 | 24.16 Mn |
| Sep 30, 2023 | 24.16 Mn |
| Dec 31, 2022 | 56.70 Mn |
| Dec 31, 2022 | 56.70 Mn |
| Sep 30, 2022 | 619,000.00 |
| Sep 30, 2022 | 619,000.00 |
| Jun 30, 2022 | -730,000.00 |
| Jun 30, 2022 | -730,000.00 |
| Mar 31, 2022 | -40.49 Mn |
| Mar 31, 2022 | -40.49 Mn |
| Dec 31, 2021 | 48.31 Mn |
| Dec 31, 2021 | 48.31 Mn |
| Sep 30, 2021 | -40.63 Mn |
| Sep 30, 2021 | -40.63 Mn |